|
|
Volumn 26, Issue 1, 2005, Pages 180-181
|
|
Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertension (multiple letters) [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BOSENTAN;
ILOPROST;
TADALAFIL;
ADULT;
BLOOD PRESSURE REGULATION;
CASE REPORT;
DRUG RESPONSE;
EXERCISE TOLERANCE;
HUMAN;
IDIOPATHIC DISEASE;
LETTER;
LUNG ARTERY PRESSURE;
MALE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
SYMPTOMATOLOGY;
SYSTOLIC BLOOD PRESSURE;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION, PULMONARY;
MALE;
PHOSPHODIESTERASE INHIBITORS;
PIPERAZINES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 21744440762
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.05.00030405 Document Type: Letter |
|
Times cited : (9)
|
|
References (0)
|
